A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Novartis Pharmaceuticals
- Study ID
- NCT07094516
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- VHB937 — BIOLOGICALVHB937 solution for infusion
- VHB937 — BIOLOGICALVHB937 solution for infusion
- Placebo — OTHERSolution for infusion
Study Details
This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.
Key Dates
- Start date
- Aug 7, 2025
- Status verified
- May 2026
- Primary completion
- Sep 14, 2028
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 407 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: VHB937 Low DoseI.V. infusions
- Experimental: VHB937 High DoseI.V. infusions
- Placebo Comparator: PlaceboI.V. infusions
Primary Outcome Measure
Change from Baseline in the Clinical Dementia Rating scale - Sum of Boxes (CDR-SB) [ Time Frame: Baseline and Week 72 ]
Central Contacts
- Novartis Pharmaceuticals1-888-669-6682
- Novartis Pharmaceuticals+41613241111
Locations (24)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Banner Alzheimers Institute | Phoenix | Arizona | 85006 | Allison Perrin (PRINCIPAL_INVESTIGATOR) |
| Irvine Center for Clinical Research | Irvine | California | 92618 | +1 949 753 1663#208 Edward Zamrini (PRINCIPAL_INVESTIGATOR) |
| University of California San Diego | La Jolla | California | 92037 | Gabriel Leger (PRINCIPAL_INVESTIGATOR) |
| University of California at Los Angeles | Los Angeles | California | 90095 | Marie Kim (PRINCIPAL_INVESTIGATOR) |
| Jem Research Institute | Atlantis | Florida | 33462-6608 | 561-968-2933 Linda Pao (PRINCIPAL_INVESTIGATOR) |
| Visionary Investigators Network | Aventura | Florida | 33180 | Jonathan Cross (PRINCIPAL_INVESTIGATOR) |
| K2 Medical Research LLC | Maitland | Florida | 32751 | Sheila Baez Torres (PRINCIPAL_INVESTIGATOR) |
| K2 Medical Research LLC | Maitland | Florida | 32751 | Craig Curtis (PRINCIPAL_INVESTIGATOR) |
| Renstar Medical Research | Ocala | Florida | 34471 | +1 813 345 8210 Anette Veronica Nieves (PRINCIPAL_INVESTIGATOR) |
| Charter Research The Villages | The Villages | Florida | 32162 | Jeffrey Norton (PRINCIPAL_INVESTIGATOR) |
| Alzheimers Research Treatment Ctr | Wellington | Florida | 33414 | Adam Falchook (PRINCIPAL_INVESTIGATOR) |
| Alzheimers Research Treatment Ctr | Wellington | Florida | 33414 | 561-209-2400 David Watson (PRINCIPAL_INVESTIGATOR) |
| Conquest Research | Winter Park | Florida | 32789 | Malisa Agard (PRINCIPAL_INVESTIGATOR) |
| Hawaii Pacific Neuroscience LLC | Honolulu | Hawaii | 96817 | Kore Liow (PRINCIPAL_INVESTIGATOR) |
| University of Kansas Hospital | Fairway | Kansas | 66205 | 913-588-0555 Townley Ryan (PRINCIPAL_INVESTIGATOR) |
| ActivMed Practices and Research | Methuen | Massachusetts | 01844 | 978-462-9571 Deborah Green-LaRoche (PRINCIPAL_INVESTIGATOR) |
| Citizens Memorial Hospital Neurology CLinic | Bolivar | Missouri | 65613 | 417-841-3643 Curtis Schreiber (PRINCIPAL_INVESTIGATOR) |
| Lou Ruvo Center for Brain Health | Las Vegas | Nevada | 89106 | 702-483-6025 Charles Bernick (PRINCIPAL_INVESTIGATOR) |
| UNC Hosp Invest Drug Serv Pharm | Chapel Hill | North Carolina | 27514 | Andrea Bozoki (PRINCIPAL_INVESTIGATOR) |
| The Ohio State University | Columbus | Ohio | 43210 | Douglas W Scharre (PRINCIPAL_INVESTIGATOR) |
| Neural Net Research | Portland | Oregon | 97225 | Michael S Mega (PRINCIPAL_INVESTIGATOR) |
| Abington Neurological Associates Ltd | Willow Grove | Pennsylvania | 19090 | +1 215 957 9250 #57 David Weisman (PRINCIPAL_INVESTIGATOR) |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229-3900 | 210-567-8229 Sudha Seshadri (PRINCIPAL_INVESTIGATOR) |
| University of Washington Medical Center | Seattle | Washington | 98195 | Michael Rosenbloom (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Dominantly Inherited Alzheimer Network (DIAN)Recruiting · Washington University School of Medicine · Jacksonville, Florida
- Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into StudiesRecruiting · Banner Health · Phoenix, Arizona
- PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric DiseasesPHASE1/PHASE2 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's DiseaseRecruiting · Douglas Scharre · Columbus, Ohio